KR100746444B1 - 설사-우세형 과민성 대장 증후군의 치료제 - Google Patents

설사-우세형 과민성 대장 증후군의 치료제 Download PDF

Info

Publication number
KR100746444B1
KR100746444B1 KR1020057016208A KR20057016208A KR100746444B1 KR 100746444 B1 KR100746444 B1 KR 100746444B1 KR 1020057016208 A KR1020057016208 A KR 1020057016208A KR 20057016208 A KR20057016208 A KR 20057016208A KR 100746444 B1 KR100746444 B1 KR 100746444B1
Authority
KR
South Korea
Prior art keywords
bowel syndrome
irritable bowel
diarrhea
parts
ramosetron
Prior art date
Application number
KR1020057016208A
Other languages
English (en)
Korean (ko)
Other versions
KR20060052661A (ko
Inventor
아키토 니시다
아키라 니와
유타카 아쯔타
Original Assignee
아스텔라스세이야쿠 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/JP2004/000896 external-priority patent/WO2004066998A1/ja
Priority claimed from PCT/JP2004/006657 external-priority patent/WO2005073220A1/ja
Application filed by 아스텔라스세이야쿠 가부시키가이샤 filed Critical 아스텔라스세이야쿠 가부시키가이샤
Publication of KR20060052661A publication Critical patent/KR20060052661A/ko
Application granted granted Critical
Publication of KR100746444B1 publication Critical patent/KR100746444B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1020057016208A 2004-01-30 2005-01-27 설사-우세형 과민성 대장 증후군의 치료제 KR100746444B1 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
WOPCT/JP2004/000896 2004-01-30
PCT/JP2004/000896 WO2004066998A1 (ja) 2003-01-31 2004-01-30 安定な経口用固形医薬組成物
WOPCT/JP2004/006657 2004-05-12
PCT/JP2004/006657 WO2005073220A1 (ja) 2004-01-30 2004-05-12 下痢型過敏性腸症候群治療剤

Publications (2)

Publication Number Publication Date
KR20060052661A KR20060052661A (ko) 2006-05-19
KR100746444B1 true KR100746444B1 (ko) 2007-08-03

Family

ID=34650735

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020057016208A KR100746444B1 (ko) 2004-01-30 2005-01-27 설사-우세형 과민성 대장 증후군의 치료제

Country Status (6)

Country Link
EP (1) EP1559446B1 (ru)
JP (1) JP3763360B2 (ru)
KR (1) KR100746444B1 (ru)
CN (1) CN100372533C (ru)
ES (1) ES2367896T3 (ru)
RU (1) RU2351327C2 (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4632204B2 (ja) * 2005-09-21 2011-02-16 アステラス製薬株式会社 下痢型過敏性腸症候群治療剤
KR20110045027A (ko) * 2008-08-28 2011-05-03 아스텔라스세이야쿠 가부시키가이샤 과민성 장 증후군의 치료 방법
JP5741433B2 (ja) * 2009-06-30 2015-07-01 アステラス製薬株式会社 緩解期の炎症性腸疾患患者における排便異常治療剤
JP5938886B2 (ja) * 2010-12-14 2016-06-22 アステラス製薬株式会社 活動期の炎症性腸疾患患者における排便異常治療剤
JP5365949B2 (ja) * 2011-10-28 2013-12-11 アステラス製薬株式会社 低用量ラモセトロン含有口腔内崩壊錠
JP6355806B1 (ja) * 2017-09-04 2018-07-11 株式会社三和化学研究所 ラクツロースを有効成分とする便秘症治療剤
CN116133722A (zh) 2020-07-21 2023-05-16 帝人制药株式会社 光线照射装置

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9721139D0 (en) * 1997-10-07 1997-12-03 Glaxo Group Ltd Medicaments
US6566369B2 (en) * 2000-07-26 2003-05-20 Solvay Pharmaceuticals Gmbh Medicament containing cilansetron for the treatment of non-obstipative male irritable bowel syndrome patients

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Expert Opin Pharmacother. 2003 Nov;4(11):2089-98
J Gastroenterol. 1994 Dec; 29(6):721-6
Venture 2003, 35(10), 26-29
국제공개특허 제02/07713호

Also Published As

Publication number Publication date
KR20060052661A (ko) 2006-05-19
RU2351327C2 (ru) 2009-04-10
JP3763360B2 (ja) 2006-04-05
ES2367896T3 (es) 2011-11-10
JP2005213244A (ja) 2005-08-11
EP1559446B1 (en) 2011-07-13
CN1764453A (zh) 2006-04-26
RU2007119067A (ru) 2008-11-27
EP1559446A1 (en) 2005-08-03
CN100372533C (zh) 2008-03-05

Similar Documents

Publication Publication Date Title
JP4632204B2 (ja) 下痢型過敏性腸症候群治療剤
KR100746444B1 (ko) 설사-우세형 과민성 대장 증후군의 치료제
US11033532B2 (en) Uses of benzimidazole derivative for nocturnal acid breakthrough
RU2284819C2 (ru) Стабильная пероральная твердая композиция лекарственного препарата
US20190192525A1 (en) Apilimod compositions and methods for using same
US20080161307A1 (en) Organic Compounds
US7683090B2 (en) Treating agent for irritable bowel syndrome
CN106146558A (zh) 新的噁唑烷酮类化合物及其制备方法
CA2516433C (en) Ramosetron hydrochloride for diarrhea-predominant irritable bowel syndrome
TW201934123A (zh) 預防或治療癌症之包含pi3激酶抑制劑與細胞毒性抗癌物的醫藥組成物
WO2005073220A1 (ja) 下痢型過敏性腸症候群治療剤
JP5440502B2 (ja) 過敏性腸症候群の治療方法
KR100701409B1 (ko) 호박산 수마트립탄을 함유하는 약제학적 조성물
KR20120111954A (ko) 완해기의 염증성 장질환 환자에서의 배변 이상 치료제
KR20030019951A (ko) 변비가 없는 남성 과민성대장증후군 환자의 치료를 위한실란세트론 함유 의약

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
A101 Application to extend term of patent right by permit
FPAY Annual fee payment

Payment date: 20120629

Year of fee payment: 6

FPAY Annual fee payment

Payment date: 20130705

Year of fee payment: 7

FPAY Annual fee payment

Payment date: 20150626

Year of fee payment: 9

FPAY Annual fee payment

Payment date: 20160630

Year of fee payment: 10

FPAY Annual fee payment

Payment date: 20170704

Year of fee payment: 11

FPAY Annual fee payment

Payment date: 20180628

Year of fee payment: 12

FPAY Annual fee payment

Payment date: 20190627

Year of fee payment: 13